Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials
Jeffrey O. Urieto, TieFu Liu, Jennifer H. Black, Kimberley A. Cohen, Philip D. Hall, Mark C. Willingham, Lewis K. Pennell, Donna E. Hogge, Robert J. Kreitman, Arthur E. Frankel
Dive into the research topics of 'Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials'. Together they form a unique fingerprint.